查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1732960

維生素 B2 市場 - 全球產業規模、佔有率、趨勢、機會和預測（按銷售管道、最終用途、地區和競爭細分，2020-2030 年）

Vitamin B2 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球維生素 B2 市值為 4.977 億美元，預計到 2030 年將達到 7.2199 億美元，複合年成長率為 4.20%。維生素 B2（核黃素）作為一種重要的水溶性營養素，支持能量產生和細胞功能，推動了注重健康的消費者群體對其的需求。人們對預防性醫療保健和營養的認知不斷提高，促進了人們對富含維生素的補充劑和強化食品的攝取。核黃素被廣泛認為可以促進新陳代謝、皮膚健康和神經功能。此外，它在動物飼料領域的使用對於改善牲畜的生長、免疫力和生殖健康起著至關重要的作用。新興市場對優質肉類和乳製品的消費不斷成長，進一步推動了對維生素強化飼料解決方案的需求。

市場概覽
預測期 2026-2030
2024年市場規模 4.977億美元
2030年市場規模 7.2199億美元
2025-2030 年複合年成長率 4.20%
成長最快的領域 直接的
最大的市場 北美洲

關鍵市場促進因素

製藥業的成長

主要市場挑戰

原料供應波動

主要市場趨勢

對天然資源的偏好日益增加

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球維生素 B2 市場的影響

第5章：全球維生素B2市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按銷售管道（直接、間接）
    • 依最終用途（動物飼料、藥品和補充劑、食品和飲料強化劑、著色劑、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美維生素B2市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲維生素B2市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太維生素B2市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美維生素B2市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲維生素B2市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球維生素 B2 市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Hubei Guangji Pharmaceutical Co., Ltd
  • dsm-firmenich
  • BASF SE
  • Haijianuo Pharmaceutical Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co Ltd.
  • Shandong Hongda Biological Technology Co., Ltd.
  • Xinfa Pharmaceutical Co. Ltd
  • NB Group Co. Ltd

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29219

The Global Vitamin B2 Market was valued at USD 497.70 million in 2024 and is projected to reach USD 721.99 million by 2030, growing at a CAGR of 4.20%. As a vital water-soluble nutrient, Vitamin B2 (riboflavin) supports energy production and cellular functions, driving its demand across health-conscious consumer segments. Increasing awareness around preventive healthcare and nutrition has encouraged the uptake of vitamin-enriched supplements and fortified foods. Riboflavin is widely recognized for promoting metabolism, skin health, and neurological function. Additionally, its use in the animal feed sector plays a crucial role in improving livestock growth, immunity, and reproductive health. The rising consumption of high-quality meat and dairy in emerging markets is further propelling demand for vitamin-enhanced feed solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 497.70 Million
Market Size 2030USD 721.99 Million
CAGR 2025-20304.20%
Fastest Growing SegmentDirect
Largest MarketNorth America

Key Market Drivers

Growth in Pharmaceutical Industry

The rapid expansion of the pharmaceutical industry has become a key driver for the global Vitamin B2 (riboflavin) market. With the pharmaceutical sector surpassing USD 1.6 trillion in revenue by 2023, riboflavin has gained prominence due to its critical functions in energy metabolism, antioxidant activity, and enzymatic reactions. Its inclusion in therapeutic products for addressing nutritional deficiencies and chronic fatigue highlights its medicinal significance. Notably, Eisai Co., Ltd.'s introduction of "Chocola BB Royal T" underscores this trend, utilizing activated vitamin B2 alongside royal jelly and taurine to boost energy metabolism. The growing prevalence of non-communicable diseases and malnutrition globally continues to bolster demand for riboflavin-based formulations.

Key Market Challenges

Volatility in Raw Material Supply

The Vitamin B2 market faces significant constraints due to unstable raw material supplies, which elevate production costs and disrupt availability. Key inputs such as fermentation substrates and chemical precursors often originate from geographically concentrated sources, making them susceptible to geopolitical instability, trade limitations, and environmental disruptions. Events like natural disasters, workforce shortages, and regulatory shifts in major supplier regions further aggravate supply chain uncertainties. These factors collectively strain manufacturers, threatening consistent product delivery and market stability.

Key Market Trends

Rising Preference for Natural Sources

A growing global shift toward natural, clean-label, and organic products is significantly influencing the Vitamin B2 market. Consumers are increasingly favoring riboflavin derived from microbial fermentation processes, which are viewed as safer and more environmentally sustainable compared to synthetic alternatives. The surge in organic food sales-from USD 18 billion in 2000 to over USD 136 billion by 2023-highlights this consumer transition. This trend is driven by heightened health awareness and scrutiny over artificial additives, prompting manufacturers to prioritize natural, non-GMO, and sustainably sourced ingredients.

Key Market Players

  • Hubei Guangji Pharmaceutical Co., Ltd
  • dsm-firmenich
  • BASF SE
  • Haijianuo Pharmaceutical Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co Ltd.
  • Shandong Hongda Biological Technology Co., Ltd.
  • Xinfa Pharmaceutical Co. Ltd
  • N.B Group Co. Ltd

Report Scope

In this report, the Global Vitamin B2 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B2 Market, By Sales Channel:

  • Direct
  • Indirect

Vitamin B2 Market, By End Use:

  • Animal feed
  • Pharmaceuticals & Supplements
  • Food & Beverage Fortification
  • Colorant
  • Others

Vitamin B2 Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B2 Market.

Available Customizations:

Global Vitamin B2 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin B2 Market

5. Global Vitamin B2 Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Animal feed, Pharmaceuticals & Supplements, Food & Beverage Fortification, Colorant, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Vitamin B2 Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin B2 Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Vitamin B2 Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Vitamin B2 Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin B2 Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Vitamin B2 Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Vitamin B2 Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin B2 Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin B2 Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin B2 Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B2 Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin B2 Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin B2 Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Vitamin B2 Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Vitamin B2 Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin B2 Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Vitamin B2 Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Vitamin B2 Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Vitamin B2 Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Vitamin B2 Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin B2 Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Vitamin B2 Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Vitamin B2 Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Vitamin B2 Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin B2 Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hubei Guangji Pharmaceutical Co., Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. dsm-firmenich
  • 15.3. BASF SE
  • 15.4. Haijianuo Pharmaceutical Co., Ltd.
  • 15.5. Zhejiang Shengda Bio-Pharm Co Ltd.
  • 15.6. Shandong Hongda Biological Technology Co., Ltd.
  • 15.7. Xinfa Pharmaceutical Co. Ltd
  • 15.8. N.B Group Co. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer